JPH07215848A - Skin external agent and skin cosmetic - Google Patents
Skin external agent and skin cosmeticInfo
- Publication number
- JPH07215848A JPH07215848A JP6013493A JP1349394A JPH07215848A JP H07215848 A JPH07215848 A JP H07215848A JP 6013493 A JP6013493 A JP 6013493A JP 1349394 A JP1349394 A JP 1349394A JP H07215848 A JPH07215848 A JP H07215848A
- Authority
- JP
- Japan
- Prior art keywords
- skin
- analgesic
- perfume
- inflammatory
- external agent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Description
【0001】[0001]
【産業上の利用分野】本発明は皮膚外用剤及び皮膚化粧
料に関する。FIELD OF THE INVENTION The present invention relates to a skin external preparation and a skin cosmetic.
【0002】[0002]
【従来の技術】従来より、消炎鎮痛目的又は皮膚の清涼
感を得る目的としてl−メントール、ハッカ油、カプサ
イシン、カンフル等の局所刺激剤を使用している皮膚外
用剤及び皮膚化粧料があったが、それらは鼻を刺激する
強烈なハッカ臭を有しており、又局所刺激剤として消炎
鎮痛を助ける目的もしくは吸収促進剤の目的等を持ち合
わせており、消炎鎮痛目的の皮膚外用剤又、肌をひきし
め、肌に清涼感をあたえる目的の皮膚化粧料には欠かす
ことの出来ない原料であった。2. Description of the Related Art Conventionally, there have been external skin preparations and skin cosmetics which use topical stimulants such as l-menthol, peppermint oil, capsaicin, camphor and the like for the purpose of anti-inflammatory and analgesia or to obtain a refreshing feeling of the skin. However, they have a strong peppermint odor that irritates the nose, and also have the purpose of helping antiphlogistic / analgesic as a local stimulant or the purpose of absorption promoter, etc. It was an essential material for skin cosmetics for the purpose of giving a refreshing feeling to the skin.
【0003】[0003]
【発明が解決しようとする課題】これまでl−メントー
ル、ハッカ油、カプサイシン、カンフル等の局所刺激剤
は皮膚に対する吸収促進作用が強く消炎鎮痛剤の有効成
分を皮下組織にまで到達出来る点が有用視され、そのは
たらきにより消炎鎮痛目的の皮膚外用剤においてはいち
はやく消炎鎮痛効果が期待でき、又、肌に清涼感をあた
える目的の皮膚化粧料においては皮膚のほてりを抑え、
皮膚をひきしめる等の効果があり、これら消炎鎮痛目的
の皮膚外用剤、肌に清涼感をあたえる目的の皮膚化粧料
等には欠かすことのできない原料であったが、なにぶん
ハッカ臭が強く鼻粘膜を刺激する問題点等があり、人に
与える影響として、時には清涼感を通り越して不快感を
与えるものがあった。The topical stimulants such as l-menthol, peppermint oil, capsaicin, camphor and the like have a strong effect of promoting absorption on the skin and are useful in that the active ingredient of the anti-inflammatory analgesic can reach the subcutaneous tissue. In the skin external preparation for the purpose of anti-inflammatory analgesia due to its action, the anti-inflammatory analgesic effect can be expected quickly, and in the skin cosmetic for the purpose of giving a refreshing feeling to the skin, suppressing hot flashes of the skin,
It has the effect of tightening the skin, etc., and it was an essential ingredient for external skin preparations for anti-inflammatory and analgesic purposes, skin cosmetics for the purpose of giving a refreshing feeling to the skin, etc. There were problems such as irritation, and as an effect on humans, there were times when it passed the refreshing feeling and gave an unpleasant feeling.
【0004】しかし余り臭いが強いといって、これらの
吸収促進剤を使用せずに消炎鎮痛目的の皮膚外用剤、肌
に清涼感をあたえる目的の皮膚化粧料を考えるにして
も、主剤である消炎鎮痛剤の働きが充分に行うことが出
来ないと予想される。[0004] However, even if it is said that it has a strong odor, it is the main ingredient even when considering skin external preparations for the purpose of anti-inflammatory and analgesia and skin cosmetics for the purpose of giving a refreshing feeling to the skin without using these absorption promoters. It is expected that the action of anti-inflammatory analgesics cannot be fully performed.
【0005】又、臭いが人に与える影響も大きな問題で
あり、従来よりハッカ臭イコール消炎鎮痛効果、或いは
肌をひきしめる、肌のほてりを抑える等の効果として、
一般的通念となりがちな感さえある。ということは、ハ
ッカ臭は消炎鎮痛目的の皮膚外用剤、肌に清涼感をあた
える目的の皮膚化粧料等にはなくてはならない原料であ
り、コスト的な点や取扱の安易な点等を考慮すると使用
を控えることが出来づらかった。Further, the influence of odor on humans is also a big problem, and as a conventional effect of mint smell equal anti-inflammatory and analgesic effect, or the effect of tightening the skin, suppressing hot flash of the skin, etc.,
There is even a feeling that this is a common wisdom. This means that peppermint odor is an indispensable raw material for external skin preparations for anti-inflammatory and analgesic purposes, and skin cosmetics for the purpose of giving a refreshing feeling to the skin.Considerations such as cost and ease of handling. Then it was difficult to refrain from using it.
【0006】[0006]
【課題を解決するための手段】本発明者はこのような状
況に鑑み、鋭意研究を行った結果、上記課題点を解決す
る方法を生み出した。即ち、本発明は消炎鎮痛化合物、
界面活性剤、吸収促進剤、局所刺激剤、PH調整剤、防
腐剤、香料、精製水等からなる消炎鎮痛目的の皮膚外用
剤、肌に清涼感をあたえる目的の皮膚化粧料であり、以
下本発明について詳しく説明すると本発明の特徴は香料
を配合しており、好ましくは香水の香り例えば、ムスク
系、シトラス系、フローラル系を模倣した香料を使用す
ることにより、本発明品を使用開始時点は局所刺激剤と
して配合されているl−メントール、カンフル、ハッカ
油、ノニル酸ワニリルアミド、カプサイシン等の香りを
発するが、1、2分もしくは数分後に至ると前期の香水
の香りを模倣した香料の香りが発しだし、前期する局所
刺激剤の香りが消失してしまう。即ち消炎鎮痛目的の皮
膚外用剤、肌に清涼感をあたえる目的の皮膚化粧料に有
りがちなハッカ臭を損なうことなく、香水の香りを模倣
した香料の香りが持続出来る。SUMMARY OF THE INVENTION In view of such circumstances, the present inventor has conducted earnest research and, as a result, has produced a method for solving the above-mentioned problems. That is, the present invention is an anti-inflammatory analgesic compound,
A skin external preparation for the purpose of anti-inflammatory and analgesia consisting of a surfactant, an absorption promoter, a local stimulant, a pH adjuster, an antiseptic, a fragrance, purified water, etc., and a skin cosmetic for the purpose of giving a refreshing feeling to the skin. The feature of the present invention will be described in detail with reference to the invention. Preferably, a fragrance of perfume, for example, a musk-based, citrus-based, or floral-based fragrance is used to start the use of the product of the present invention. It emits the scent of l-menthol, camphor, peppermint oil, nonyl acid vanillyl amide, capsaicin, etc., which are blended as a topical stimulant, but a scent of a fragrance that imitates the scent of the perfume of the previous period after one, two or a few minutes. And the scent of the local stimulant disappears. That is, the fragrance of the fragrance imitating the scent of perfume can be maintained without impairing the mint smell that is often present in the external skin preparations for the purpose of anti-inflammatory and analgesia and the skin cosmetics for the purpose of giving the skin a refreshing feeling.
【0007】本発明に使用される消炎鎮痛化合物として
は、サリチル酸メチル、サリチル酸フェニル、サリチル
酸エチレングリコール等が挙げられ、これらは配合量
0.1〜10.0重量%とし、好ましくは1.0〜8.
0重量%、最も好ましくは3.0〜6.0重量%とする
ことが可能である。これら有効成分主剤に加えて局所刺
激剤としてl−メントール、カンフル、ハッカ油、ノニ
ル酸ワニリルアミド、カプサイシン等が挙げられ、これ
らは配合量0.1〜8.0重量%、好ましくは0.5〜
5.0重量%、最も好ましくは1.0〜4.0重量%と
することが可能である。吸収促進剤として、ベンジルア
ルコール、クロタミトン等が挙げられ、これら吸収促進
剤は配合量1〜25重量%とし、好ましくは1〜15重
量%、最も好ましくは1〜10重量%とすることが可能
である。Examples of the anti-inflammatory and analgesic compounds used in the present invention include methyl salicylate, phenyl salicylate, ethylene glycol salicylate and the like, and the compounding amount thereof is 0.1 to 10.0% by weight, preferably 1.0 to 8.
It can be 0% by weight, most preferably 3.0 to 6.0% by weight. In addition to these active ingredient bases, local stimulants include l-menthol, camphor, peppermint oil, nonyl acid vanillyl amide, capsaicin and the like, and these are compounded in amounts of 0.1 to 8.0% by weight, preferably 0.5 to
It can be 5.0% by weight, most preferably 1.0-4.0% by weight. Examples of the absorption enhancer include benzyl alcohol and crotamiton. These absorption enhancers may be contained in an amount of 1 to 25% by weight, preferably 1 to 15% by weight, and most preferably 1 to 10% by weight. is there.
【0008】界面活性剤としては陽性イオン、陰性イオ
ン、両性イオン、非イオンのいずれの界面活性剤を使用
してもよいが、より好ましくは非イオン界面活性剤を使
用することが望ましい。非イオン界面活性剤を例として
挙げると、ソルビタン脂肪酸エステル、グリセリン脂肪
酸エステル、ポリグリセリン脂肪酸エステル、ポリオキ
シエチレンソルビタン脂肪酸エステル、ポリオキシエチ
レンソルビット脂肪酸エステル、ポリオキシエチレング
リコール脂肪酸エステル、ポリオキシエチレン硬化ヒマ
シ油、ポリオキシエチレンアルキルエ−テル、ポリオキ
シエチレンポリオキシプロピレンアルキルエ−テル、ポ
リオキシエチレンフェニルエ−テル、高級アルコ−ルリ
ン酸エステル等が挙げられる。これらの界面活性剤は一
種もしくは二種以上の組み合わせで使用する事も可能で
あり、これらは配合量0.1〜15.0重量%、好まし
くは0.5〜10.0重量%、最も好ましくは1.0〜
5.0重量%の範囲で配合することが可能である。As the surfactant, any of positive ion, negative ion, amphoteric ion and nonionic surfactant may be used, but it is more preferable to use nonionic surfactant. Examples of nonionic surfactants include sorbitan fatty acid ester, glycerin fatty acid ester, polyglycerin fatty acid ester, polyoxyethylene sorbitan fatty acid ester, polyoxyethylene sorbit fatty acid ester, polyoxyethylene glycol fatty acid ester, and polyoxyethylene cured castor. Examples thereof include oil, polyoxyethylene alkyl ether, polyoxyethylene polyoxypropylene alkyl ether, polyoxyethylene phenyl ether, and higher alcohol phosphate ester. These surfactants can be used alone or in combination of two or more, and these are contained in an amount of 0.1 to 15.0% by weight, preferably 0.5 to 10.0% by weight, most preferably Is 1.0-
It is possible to mix in the range of 5.0% by weight.
【0009】又、これらの界面活性剤の乳化を助ける目
的で乳化補助剤を配合する事ができ、又これらの乳化補
助剤としては、ステアリルアルコール、セトステアリル
アルコール、セタノール、コレステロール、ベヘニルア
ルコール等が挙げられる。その他消炎鎮痛化合物,局所
刺激剤,吸収促進剤等が皮膚に円滑に延び易くする目
的,又は揮発を徐々に行える目的としてシリコ−ン化合
物を配合する事も可能であり,配合量0.1〜1.0重
量%,好ましくは0.1〜0.8重量%、最も好ましく
は0.1〜0.5重量%とする。Further, an emulsification auxiliary agent can be blended for the purpose of assisting the emulsification of these surfactants. Examples of these emulsification auxiliary agents include stearyl alcohol, cetostearyl alcohol, cetanol, cholesterol and behenyl alcohol. To be In addition, it is possible to add a silicone compound for the purpose of facilitating smooth spreading of the anti-inflammatory analgesic compound, topical stimulant, absorption enhancer, etc. to the skin, or for the purpose of gradually volatilizing the compound. It is 1.0% by weight, preferably 0.1 to 0.8% by weight, and most preferably 0.1 to 0.5% by weight.
【0010】PH調整剤としては水酸化ナトリウム、水
酸化カリウム、アンモニア水等の無機塩基、トリイソプ
ロパノールアミン、ジイソプロパノールアミン、トリエ
タノールアミン、ジエタノールアミン等の有機塩基が挙
げられる。これらのPH調整剤は0.01〜5.0重量
%の配合量で製品のPH4〜8となる量を配合量とす
る。その他防腐剤としては、メチルパラベン、エチルパ
ラベン、プロピルパラベン、チモール、イソプロピルメ
チルフェノール等が用いられ配合量は適量配合とする。
又、使用感を向上させる目的により湿潤剤を配合可能で
あり、湿潤剤としてはプロピレングリコール、1−3ブ
チレングリコール、dlピロリドンカルボン酸ナトリウ
ム、グリセリン、dソルビトール等を配合することがで
きる。Examples of the pH adjusting agent include inorganic bases such as sodium hydroxide, potassium hydroxide and aqueous ammonia, and organic bases such as triisopropanolamine, diisopropanolamine, triethanolamine and diethanolamine. The blending amount of these PH adjusting agents is such that the blending amount of 0.01 to 5.0% by weight results in PH4 to 8 of the product. As other preservatives, methylparaben, ethylparaben, propylparaben, thymol, isopropylmethylphenol and the like are used, and the compounding amount is appropriate.
A wetting agent can be added for the purpose of improving the feeling of use, and as the wetting agent, propylene glycol, 1-3 butylene glycol, sodium dl pyrrolidonecarboxylate, glycerin, dsorbitol or the like can be added.
【0011】以下に本発明の製造方法を示す。本発明の
皮膚外用剤及び皮膚化粧料を製造する為には、有効成分
として消炎鎮痛化合物に吸収促進剤を加え、溶解させ
る。次に界面活性剤、乳化補助剤、局所刺激剤、吸収促
進剤、香料、防腐剤、湿潤剤等を加えた後、PH調整剤
によってPH5〜8になるように調整する。さらにその
後容器に充填し製品とする。The manufacturing method of the present invention will be described below. In order to produce the skin external preparation and skin cosmetic of the present invention, an absorption enhancer is added to and dissolved in an anti-inflammatory analgesic compound as an active ingredient. Next, after adding a surfactant, an emulsification aid, a local stimulant, an absorption promoter, a fragrance, an antiseptic, a moistening agent, etc., the pH is adjusted with a pH adjuster to a pH of 5-8. After that, it is filled in a container to obtain a product.
【0012】[0012]
【作用】上記のように構成された皮膚外用剤、皮膚化粧
料においては従来ある消炎鎮痛剤及び皮膚化粧料にある
メントール臭が長期に渡って漂うことなく、皮膚に皮膚
外用剤、皮膚化粧料を塗布した場合塗布当初はハッカ臭
がするものの2、3分後には配合されてある香料の香り
が漂い始め、それが長期に渡って持続するため心地良い
香りが漂う。香料の種類としてはムスク系、フローラル
系、シトラス系等が挙げられる。In the skin external preparation and the skin cosmetic having the above-mentioned structure, the skin external preparation and the skin cosmetic do not linger on the skin for a long period of time without the anti-inflammatory analgesic and the menthol odor that are present in the skin cosmetic. When applied, there is a minty smell at the beginning of application, but after a few minutes, the fragrance of the fragrance that has been blended begins to drift, and since it lasts for a long time, a pleasant scent drifts. Examples of the fragrance include musk-based, floral-based, citrus-based and the like.
【0013】[0013]
【実施例】次に、本発明に於ける実施例として、本発明
の皮膚外用剤、皮膚化粧料の形態をそれぞれその組成と
共に示す。EXAMPLES Next, as examples of the present invention, the forms of the external preparation for skin and skin cosmetics of the present invention will be shown together with their compositions.
【0014】[0014]
【表1】 [Table 1]
【0015】[0015]
【表2】 [Table 2]
【0016】[0016]
【表3】 [Table 3]
【0017】[0017]
【発明の効果】以上のように実施例として挙げた例はご
く一部であり、それぞれ香料の香りが漂う中に、消炎鎮
痛感、清涼感等が効果的に現れる。EFFECTS OF THE INVENTION As described above, only a few examples are given, and the anti-inflammatory and analgesic sensations, the refreshing sensation, etc. effectively appear while the fragrance of the fragrance is drifting.
【0018】皮膚刺激性テストを健康な女性30名に対
して行った。実施例に挙げる皮膚外用剤を試料としてク
ローズドパッチテストによる皮膚刺激性テストである。
1cm四方のガーゼ2枚に試料を浸し、他のガーゼ2枚に
は水を浸した、計4枚のガーゼをそれぞれ被験者の前碗
部内側にクローズドパッチした。24時間後、48時間
後にそれぞれガーゼを取り外し、試験開始後30分後と
24時間後、48時間後の皮膚の状態を調べた結果、皮
膚刺激性は全く見られなかった。A skin irritation test was performed on 30 healthy women. It is a skin irritation test by a closed patch test using the skin external preparations mentioned in the examples as samples.
A sample was dipped in two pieces of 1 cm square gauze and water was dipped in the other two pieces of gauze, and a total of four pieces of gauze were closed-patched inside the anterior bowl of each subject. Gauze was removed after 24 hours and 48 hours, and the skin condition was examined 30 minutes, 24 hours, and 48 hours after the start of the test. As a result, no skin irritation was observed.
───────────────────────────────────────────────────── フロントページの続き (51)Int.Cl.6 識別記号 庁内整理番号 FI 技術表示箇所 A61K 31/165 9454−4C 35/78 C 8217−4C ─────────────────────────────────────────────────── ─── Continuation of the front page (51) Int.Cl. 6 Identification code Internal reference number FI Technical display area A61K 31/165 9454-4C 35/78 C 8217-4C
Claims (1)
ン、カンフル等の局所刺激剤を含む消炎鎮痛剤に於いて
香料を配合してなる皮膚外用剤、皮膚化粧料。1. A skin external preparation or a skin cosmetic, which comprises a perfume in an anti-inflammatory analgesic containing a local stimulant such as l-menthol, peppermint oil, capsaicin, camphor and the like.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP6013493A JPH07215848A (en) | 1994-02-07 | 1994-02-07 | Skin external agent and skin cosmetic |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP6013493A JPH07215848A (en) | 1994-02-07 | 1994-02-07 | Skin external agent and skin cosmetic |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH07215848A true JPH07215848A (en) | 1995-08-15 |
Family
ID=11834649
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP6013493A Pending JPH07215848A (en) | 1994-02-07 | 1994-02-07 | Skin external agent and skin cosmetic |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH07215848A (en) |
Cited By (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0950399A3 (en) * | 1998-02-23 | 2001-03-21 | Takasago Institute For Interdisciplinary Science Inc. | Fragrance compositions having antimicrobial activity |
WO2001041715A3 (en) * | 1999-12-02 | 2002-07-11 | Cp Hall Co | Ultraviolet radiation absorbing waxes useful in cosmetic compositions |
WO2003074622A1 (en) * | 2002-03-01 | 2003-09-12 | Takasago International Corporation | Refrigerant compositions, refrigerant auxiliary compositions and uses thereof |
JP2006151971A (en) * | 2004-11-05 | 2006-06-15 | Maruishi Pharmaceutical Co Ltd | Insulin-like growth factor-1 secretion promoter |
KR100720671B1 (en) * | 2006-02-23 | 2007-05-21 | 경희대학교 산학협력단 | The composition comprising extracts of gentiana scabra, citrus unshiu marcor and coptis chinensis for treatment of type iv allergy and an inflammation |
WO2009123003A1 (en) * | 2008-03-31 | 2009-10-08 | ロート製薬株式会社 | Composition for external application to skin |
JP2012246324A (en) * | 2012-09-18 | 2012-12-13 | Sosin:Kk | External skin care preparation |
US9364402B1 (en) | 2014-12-31 | 2016-06-14 | The Dial Corporation | Analgesic cleansing composition |
JP2016140300A (en) * | 2015-01-30 | 2016-08-08 | ハウスウェルネスフーズ株式会社 | Composition containing capsicum extract and/or ginger extract, and production method thereof |
JP2017075129A (en) * | 2015-10-16 | 2017-04-20 | 株式会社マンダム | TRPV1 activity inhibitor |
JP2017095427A (en) * | 2015-11-27 | 2017-06-01 | ライオン株式会社 | Dissolution type microneedle pharmaceutical preparation |
JP2018127440A (en) * | 2017-02-08 | 2018-08-16 | 大学共同利用機関法人自然科学研究機構 | Activity inhibitor and hyperesthesia inhibitor |
-
1994
- 1994-02-07 JP JP6013493A patent/JPH07215848A/en active Pending
Cited By (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0950399A3 (en) * | 1998-02-23 | 2001-03-21 | Takasago Institute For Interdisciplinary Science Inc. | Fragrance compositions having antimicrobial activity |
WO2001041715A3 (en) * | 1999-12-02 | 2002-07-11 | Cp Hall Co | Ultraviolet radiation absorbing waxes useful in cosmetic compositions |
WO2003074622A1 (en) * | 2002-03-01 | 2003-09-12 | Takasago International Corporation | Refrigerant compositions, refrigerant auxiliary compositions and uses thereof |
JP2006151971A (en) * | 2004-11-05 | 2006-06-15 | Maruishi Pharmaceutical Co Ltd | Insulin-like growth factor-1 secretion promoter |
KR100720671B1 (en) * | 2006-02-23 | 2007-05-21 | 경희대학교 산학협력단 | The composition comprising extracts of gentiana scabra, citrus unshiu marcor and coptis chinensis for treatment of type iv allergy and an inflammation |
WO2009123003A1 (en) * | 2008-03-31 | 2009-10-08 | ロート製薬株式会社 | Composition for external application to skin |
JP2012246324A (en) * | 2012-09-18 | 2012-12-13 | Sosin:Kk | External skin care preparation |
US9364402B1 (en) | 2014-12-31 | 2016-06-14 | The Dial Corporation | Analgesic cleansing composition |
WO2016109243A1 (en) * | 2014-12-31 | 2016-07-07 | The Dial Corporation | Analgesic cleansing composition |
JP2016140300A (en) * | 2015-01-30 | 2016-08-08 | ハウスウェルネスフーズ株式会社 | Composition containing capsicum extract and/or ginger extract, and production method thereof |
JP2017075129A (en) * | 2015-10-16 | 2017-04-20 | 株式会社マンダム | TRPV1 activity inhibitor |
JP2017095427A (en) * | 2015-11-27 | 2017-06-01 | ライオン株式会社 | Dissolution type microneedle pharmaceutical preparation |
JP2018127440A (en) * | 2017-02-08 | 2018-08-16 | 大学共同利用機関法人自然科学研究機構 | Activity inhibitor and hyperesthesia inhibitor |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6030948A (en) | Hair regeneration compositions for treatment of alopecia and methods of application related thereto | |
US20060093689A1 (en) | Skin cosmetics | |
JP2007016045A (en) | Cosmetic compositions containing rosemary extract and dha | |
JPH07215848A (en) | Skin external agent and skin cosmetic | |
US6194468B1 (en) | Hair growth stimulants | |
JP2001131026A (en) | Cosmetic for scalp and hair | |
EP1146852B1 (en) | A cosmetic composition based on menthol and menthyl lactate, having little odor and being non-irritating | |
JP3995720B2 (en) | Cosmetic body care preparation and process for its production | |
JPH11286423A (en) | Composition for suppressing body odor | |
JPH03193727A (en) | Underarm deodorant | |
DE2557365C2 (en) | Use of polyvinylpyrrolidone to quench unwanted odors | |
JP2000198719A (en) | Hair growing agent | |
JP2002332240A (en) | Hair grower composition | |
JPH10265340A (en) | Composition for head containing methylenedioxybenzene ring-aliphatic compound | |
JPH03141213A (en) | Hair tonic | |
JPH11302133A (en) | Cosmetic for scalp and hair | |
JPH08259465A (en) | External preparation for treating skin desease | |
JP4740588B2 (en) | Cosmetic kit and skin care method using the same | |
RU2144349C1 (en) | Deodorant | |
EP3319584B1 (en) | Use of n-alkyl amide as an antiperspirant agent | |
JPS60237011A (en) | Hair tonic composition | |
JP2003012470A (en) | Hair-growing cosmetic | |
JPH10316543A (en) | Composition for head | |
JPH09249549A (en) | Cosmetic composition | |
JPH05320023A (en) | Skin cosmetic composition |